EDAP TMS: A Little Medical Growth Gem
The company is already growing sequentially, even if 2020 revenues were down on those in 2019. Still small in relation to a large and growing TAM, and working on an […]
The company is already growing sequentially, even if 2020 revenues were down on those in 2019. Still small in relation to a large and growing TAM, and working on an […]
After Verizon renewed its contract with the competition, Smith acquired that business from Avast, making it the dominant player. This is distinctly second best to winning Verizon outright as there […]
The company’s generic technology provides important benefits and is applicable in a wide range of situations. The company has two dozen shots at goal and is still adding. Cash isn’t […]
The company sells Napster, liberating itself from a stagnant legacy business and greatly improving its balance sheet. The company has a few growth jewels although it’s difficult to determine exactly […]
Another victim of the tech selloff, but company developments give basis for optimism. The company keeps on signing new deals and opening up new revenue streams, although these are in […]
The company is getting ever more entrenched in the healthcare sector, growing with their customers, adding new ones, and adding new solutions and through M&A. Adjusted EBITDA growing much faster […]
Investors are buffeted through the Covid testing bonanza and the prospect of these, good for 90%+ of revenues, disappearing, with the tech selloff to boot. This explains the extreme volatility […]
The market fears that the pandemic related work from home growth spurt in the company’s sales has come to an end. While that might very well be true, we think […]
Our worries about deteriorating credit risk due to the pandemic haven’t materialized. At present, the company isn’t very profitable, doesn’t generate cash, and doesn’t have a strong balance sheet, but […]
The company is clearing up its act, focusing on its small business SaaS IR platform, which has been fortified with the acquisition of LD Micro. Growth has returned, operational costs […]